OrthoPediatrics Past Earnings Performance

Past criteria checks 0/6

OrthoPediatrics has been growing earnings at an average annual rate of 9.2%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 19.3% per year.

Key information

9.2%

Earnings growth rate

16.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate19.3%
Return on equity-5.6%
Net Margin-14.1%
Next Earnings Update06 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How OrthoPediatrics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:2X7 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23149-2112710
30 Sep 23142-221229
30 Jun 2313711169
31 Mar 2313041088
31 Dec 2212211048
30 Sep 221169998
30 Jun 22106-12937
31 Mar 22100-15886
31 Dec 2198-16866
30 Sep 2192-30816
30 Jun 2189-33806
31 Mar 2176-38745
31 Dec 2071-33705
30 Sep 2071-23665
30 Jun 2070-22635
31 Mar 2074-15606
31 Dec 1973-13576
30 Sep 1968-11535
30 Jun 1963-10495
31 Mar 1960-10485
31 Dec 1858-12485
30 Sep 1855-25484
30 Jun 1851-26464
31 Mar 1848-26424
31 Dec 1746-24373
30 Sep 1743-14323
30 Jun 1741-13312
31 Mar 1739-12292
31 Dec 1637-12282
31 Mar 1633-12282
31 Dec 1531-13262
31 Dec 1424-13222

Quality Earnings: 2X7 is currently unprofitable.

Growing Profit Margin: 2X7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2X7 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.2% per year.

Accelerating Growth: Unable to compare 2X7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2X7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 2X7 has a negative Return on Equity (-5.56%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.